|801-2, Jindong Mansion, No. 536 Xueshi Road, Yinzhou, Ningbo 315100, P.R.Chinafirstname.lastname@example.org|
|Place of Origin:||China|
|Minimum Order Quantity:||3000 PCS|
|Packaging Details:||QTY/BOX:40PCS, Box Size:27*12*6cm; QTY/CTN:1000PCS , Carton Size:46*36*30cm|
|Supply Ability:||500000 Piece/Pieces per Month|
|Product:||CE Urine Rapid COC Drug Of Abuse Test Kit||Properties:||Pathological Analysis Equipments|
diabetes test machine,
insulin injection equipment
High Precision Pathological Analysis Equipments Urine Rapid COC Drug Of Abuse Test Kit With CE Certificate
|Product: CE certificate urine rapid COC drug of abuse test kit||Product Type:Pathological Analysis Equipments|
|Properties: Pathological Analysis Equipments||Specimen:Urine|
|Shelf Life: 24 Months||Feature:High sensitivity,simple,easy and accurate|
|Instrument classification: Class II||Size:3.0mm,4.0mm|
|Packing:QTY/BOX:40,Box Size:27*12*6cm;QTY/CTN:1000PCS||Storage:At Room Temperature|
|Model Number:N-COC||Shipping:By sea/By air/TNT/Fedex/DHL|
Range of application
Interpretation Of Results:
NEGATIVE:Two lines appear. One colored line should be in the control region (C), and another apparent colored or
pink line should be in the test region (T). This negative result indicates that the drug concentration is below
the detectable level.
NOTE: The shade of colored in the test region (T) may vary, but it should be considered negative whenever there
is even a faint pink line.
POSITIVE: One colored line appears in the control region (C). No line appears in the test region (T). This
positive result indicates that the drug concentration exceeds the detectable level.
INVALID: Control line fails to appear. Insufficient specimen volume or incorrect procedural techniques are the
most likely reasons for control line failure. Review the procedure and repeat the test with a new test device.
If the problem persists, discontinue using the test kit immediately and contact your local distributor.
The purpose of the development of pathological analysis paper is to diagnose patients quickly, conveniently and
accurately.Now pathological analysis paper has been widely used in the world, not only self-test, but also in hospitals
and centers for disease control and prevention.The accuracy rate of a single pathological analysis paper is more
than 95%. If the results of two or more tests of different brands of test paper are the same, the test results can be
considered as 99% accurate.
Newlystar (Ningbo) Medtech Co.,Ltd. is one of the leading supplier for Pathological Analysis Equipments,
Diabetes Treatment Equipment and Finished Pharmaceutical from China. With a proven track record of
passed years,Newlystar-Medtech has been recognized by her customers as a high-quality and reliable
supplier notonly on products, but also on assistance for audit and improvement of GMP level, quality
management system, EHS management system and registration dossier support, etc.The essence of
Newlystar-Medtech's activites, is a commitment to her customers with professional service and high-quality
products with effective cost and innovative solutions.
All medical product work in Newlystar-Medtech like a bridge link the customers and Chinese manufacturers,
especially, their professional working is to make the formulation manufacturers who is familiar with
Chinese medical product to understand well the international requirement,to ensure the success of customers.
The advantages on professional working and strongly representative base on first-class manufacturing partners
in China, enable Newlystar-Medtech to provide her customers with a wide range and high-tech products,
best services and capabilities for their actions in tender, distributing and improvement in their national healthcare
system. Newlystar-Medtech also dedicates herself to sourcing quality medical products for Chinese market.
Contact Person: Jocelyn